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Abstract
By comparing and measuring covariations of viral protein sequences from isolates of the
2009 pH1N1 influenza A virus (IAV), specific substitutions that co-occur in the NP-NA pair
were identified. To investigate the effect of these co-occurring substitution pairs, the V100I
substitution in NP and the D248N substitution in NA were introduced into laboratory-adapted
WSN IAVs. The recombinant WSN with the covarying NPV100I-NAD248N pair exhibited
enhanced pathogenicity, as characterized by increased viral production, increased death
and inflammation of host cells, and high mortality in infected mice. Although direct interac-
tions between the NPV100I and NAD248N proteins were not detected, the RNA-binding ability
of NPV100I was increased, which was further strengthened by NAD248N, in expression-plas-
mid-transfected cells. Additionally, the NAD248N protein was frequently recruited within lipid
rafts, indirectly affecting the RNA-binding ability of NP as well as viral release. Altogether,
our data indicate that the covarying NPV100I-NAD248N pair obtained from 2009 pH1N1 IAV
sequence information function together to synergistically augment viral assembly and
release, which may explain the observed enhanced viral pathogenicity.
Introduction
The genome of influenza A virus (IAV), a member of the Orthomyxoviridae family, consists of
a segmented negative-sense single-strand RNA, and changes in the influenza viral genome are
frequent events due to the accumulation of mutations and reassortment of RNA segments [1].
In addition to seasonal flu, IAV pandemic infections occasionally occur, with severe impacts
on public health and society. There have been extensive efforts using various approaches to
understand the nature of influenza pandemics. Among them, sequence comparison and
reverse genetics using recombinant virus in murine or primate systems have been useful for
identifying key RNA segments or sequence substitutions that contribute to influenza viral
pathogenicity.
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The 2009 pandemic H1N1 influenza A virus (2009 pH1N1 IAV) emerged and spread rap-
idly [2]. Although the 2009 H1N1 pandemic flu appeared to be mild compared to the 1918
H1N1 Spanish flu or the 1968 H3N2 Hong Kong flu, it exhibited atypical pathological poten-
tial distinct from that of seasonal influenza, with an exceptionally rapid rate of spread [3].
Sequence comparison between 2009 pH1N1 IAV and other pandemic strains has been per-
formed to characterize amino acid substitutions contributing to pathogenicity. For example,
the HA2 E47K substitution in hemagglutinin (HA) of the 2009 pH1N1 IAV reduces the pH
threshold for membrane fusion, conferring the virus with thermal stability and infectivity,
which partially explains its rapid spread and adaptation to humans [4]. Similarly, 2009 pH1N1
IAV substitutions in neuraminidase (NA) allow for low-pH stability [5]. Amino acid substitu-
tions in influenza virus PB2, PB1-F2, NP, and NS1 have also been assessed with regard to their
contributions to enhancing viral propagation and infectivity [6–9]. However, none of these
single mutations in 2009 pH1N1 IAVs sufficiently explains the pathogenicity of the 2009 pan-
demics. Notably, M2 protein channel activity enhanced 2009 pH1N1 IAV infectivity by pro-
tecting against premature HA cleavage and preserving membrane fusion competence.
Additionally, the mutant form of NP exhibits selectively reduced NA expression, thereby indi-
rectly increasing influenza virus fitness [10]. These findings indicate that two or more nonin-
teracting proteins may also elicit concerted actions and that identifying sequence variations in
viral or host factors that synergistically contribute to enhanced infection pathogenicity is
important.
During evolution, molecules that perform similar functions tend to coevolve. In addition to
physically interacting proteins, noninteracting proteins with similar functions are also
expected to coevolve [11–13]. Therefore, we utilized a methodology to search for coevolution
of amino acid sequence variations in 2009 pH1N1 IAV strains. In this report, we explore the
synergistic effects of NP and NA substitutions that may contribute to the enhancement of
influenza viral pathogenicity.
Results
Identification of covarying NP and NA pair RNA segments
To identify pairs of genetic traits that may have functioned to augment influenza viral pathoge-
nicity, we examined covariance in sequence information from the viral transcripts of pH1N1
IAV isolates obtained during the 2009 pandemic season. This identification is based on the
fact that genes that function together tend to covary during the course of evolution [11, 14]. In
total, the sequences of 417 pH1N1 virus isolates collected in 17 countries were examined (from
the Influenza Sequence & Epitope Database, ISED [15]). The number of different amino acid
sequences between any chosen gene pair among the 417 isolates was counted, and the covari-
ance of sequence variations among 10 viral proteins were compared in pairs using Pearson’s
correlation analysis (Fig 1A). Among 45 total pairwise comparisons, the covariance value of
the NP and NA pair was exceptionally high (Fig 1B and S1 Table). These results suggest that if
one virus isolate has sequence alternations in NP proteins, then it is likely that this isolate con-
tains a similar degree of sequence alternation in the NA protein as well.
We next assessed whether any specific amino acid substitutions co-occurred in NP and NA
pairs of the 2009 pH1N1 IAVs. For this purpose, amino acid sequences from the 417 isolates
were compared with those of seasonal H1N1 influenza viruses obtained from 1958 to 2008
(from ISED[15]), and variabilities at each position were separately mapped (Fig 1C). In gen-
eral, relatively high variability was observed in NP and NA sequences from seasonal H1N1
influenza strains. In contrast, NP and NA sequences from isolated 2009 pH1N1 pools were rel-
atively invariable, except for a couple of residues. For NP of the isolated 2009 pH1N1 IAVs,
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the 100th and 373th positions were highly variable. Valine (V) was observed as the 100th residue
of NP of the seasonal H1N1 IAVs, whereas an isoleucine (I) was present at this position in 75%
of the 2009 pH1N1 isolates. For residue 373, threonine (T) was dominant NP of in isolated
2009 pH1N1 IAVs, but alanine (A) was most frequent in the seasonal H1N1 NP sequence (Fig
1D). Highly variable residues at the 106th and 248th positions were also observed for NA of the
isolated 2009 pH1N1 IAVs: approximately 26% of the 2009 H1N1 isolates had V instead of I at
the 106th position of NA, and 71% had an aspartic acid (D) instead of an asparagine (N) at the
248th position (Fig 1D).
In vitro characterization of recombinant influenza A/WSN/1933 (H1N1)
viruses carrying covarying NP and NA combination pairs
We classified the NP and NA sequence information at the 100th, 373rd, 106th, and 248th posi-
tions of the 2009 pH1N1 isolates (Fig 2A). Many 2009 pH1N1 isolates had NP100I,373T/
NA106I,248D (I-T/I-D); a minor portion had NP100V,373T/NA106V,248N (V-T/V-N), NP100V,373I/
Fig 1. Identification of covarying NP and NA substitution pairs from the 2009 H1N1 influenza virus. (A) Schematic diagram identifying covarying viral proteins.
(1) Similarity plot for any chosen gene pair (genes A and B in this case) for any chosen virus isolates i and j. Covariation of genes A and B was calculated by measuring
Pearson’s correlation coefficient (ρXY) from the similarity plot. (2) Left, similarity plot for the NP and NA proteins with a ρXY = 0.623. Right, similarity plot for NP and
NS2 with a ρXY = 0.01. (B) Pearson’s correlation coefficient (ρXY) for each pair of influenza viral proteins. 1: PB2, 2: PB1, 3: PA, 4: HA, 5: NP, 6: NA, 7: M1, 8: M2, 9:
NS1, and 10: NS2. (C) Number of isolates with different amino acids at each position for the NP (left) and NA (right) proteins. For the 2009 pH1N1 IAV (red), 417
isolates were compared. For the other H1N1 strains (black), 267 isolates were compared. (D) Occurrence of amino acids at the 100th and 373th residues in NP (left) and
the 106th and 248th residues in NA (right) in the pool of 2009 H1N1 and other H1N1 isolates.
https://doi.org/10.1371/journal.pone.0217691.g001
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NA106V,248N (V-I/V-N), NP100I,373T/NA106I,248N (I-T/I-N), and NP100V,373T/NA106I,248D (V-T/
I-D), in that order. To investigate the functional characteristics of these specific amino acid
combinations of the NA and NP variants observed among the 2009 pH1N1 isolates, we gener-
ated recombinant viruses carrying these substitutions at each NP and NA position in the labo-
ratory-adapted influenza A/WSN/1933(H1N1) background strain. However, recombinant
viruses carrying NA106V,248N were not produced, even though NA proteins were expressed
(Fig 2A and S1 and S2 Figs), indicating that these NA amino acid pairs might result in a defect
in release processes. Recombinant WSN virus with the remaining combinations, namely, I-T/
I-D, I-T/I-N, and V-T/I-D, were successfully produced. As the parental WSN strain expresses
V-T/I-D and the generated recombinant viruses have the same amino acids at the 373th posi-
tion of NP and the 106th position of NA, we analyzed the combined effect of NA and NP using
recombinant viruses carrying a single substitution at the 100th position of NP (NPV100I
NAWSN) or double substitutions at the 100th position of NP and the 248th position of NA
(NPV100I NAD248N). For comparison, a recombinant WSN virus carrying NPWSN NAD248N was
also generated (Fig 2A and S2 Fig).
First, we measured the virus titer (TCID50/ml) of the recombinant WSN viruses and the rel-
ative number of virus particle present based on M gene quantitation. To evaluate the replica-
tion kinetics of the recombinant WSN viruses, A549 cells were infected with the same
amounts of recombinant WSN (10 TCID50/ml, 0.01MOI), and intracellular viral loads were
measured at 3, 6, 12, and 24 hours postinfection. The relative virus particle numbers used in
this experiment were similar in range, except for WSN viruses with the NPV100I and NAD248N
mutations (Fig 2A), which were approximately one-fifth lower. To compare the differential
kinetics of viral growth, viral loads at 6, 12, and 24 hours postinfection for each virus were sep-
arately normalized to the viral load at 3 hours postinfection for each virus. Although relative
amount of intracellular viral genome was lower with NPV100I NAD248N influenza virus infec-
tion compared to NPWSN NAWSN influenza virus infection, WSN carrying the NPV100I
NAD248N combination exhibited a high replication rate during the 24-hour period compared
to the parental or other recombinant WSN viruses (Fig 2B and 2C). This result indicates that
the presence of NAD248N in addition to NPV100I significantly enhanced relative infectivity com-
pared to that of the parental WSN virus. Although infection with either NPWSN NAD248N WSN
or NPV100I NAWSN WSN resulted in relatively higher levels of type I interferons (type I IFNs)
and inflammatory cytokines, infection with NPV100I NAD248N WSN led to enormously high
levels of cytokines, which cannot be explained by the additive effect of the dual NP and NA
substitutions (Fig 2D). We postulate that cytokine production might be indirectly enhanced by
the increased viral production of NPV100I NAD248N influenza viruses. In addition, the recombi-
nant NPV100I NAD248N WSN virus was also more toxic to host cells than was the parental or
Fig 2. Recombinant WSN carrying the NPV100I NAD248N pair exhibited enhanced pathogenicity in vitro. (A) Recombinant WSN was
generated with the designated substitutions. Frequency (%) refers to the occurrence among the 417 2009 H1N1 isolates. # the stock titer
(TCID50/ml) was assessed in A549 cells for 48 hours, ## the used volume of influenza virus stock for 1 ml of 10TCID50/ml, n.p. not
produced. (B and C) A549 cells were infected with the indicated recombinant WSN viruses (10 TCID50/ml, 0.01 MOI) for the indicated
times. Influenza HA viral RNAs were analyzed via quantitative real-time PCR (qRT-PCR). (B) The intracellular amounts of each virus at
6, 12, 24 hours postinfection was measured. The relative values to the viral load at 3 hours postinfection for each virus. (C) Same data as
(B), but relative value to the NPWSN-NAWSN influenza virus (3 hours postinfection) (D) A549 cells were infected with the indicated
recombinant viruses (10 TCID50/ml, 0.01 MOI) for 6 or 24 hours. The expression levels of type I interferons, TNFα, RANTES, and
interferon stimulated gene 15 (ISG15) were analyzed by quantitative real-time PCR (qRT-PCR). (E) A549 cells were infected with the
indicated recombinant viruses (10 TCID50/ml, 0.01 MOI) for 48 hours, and the alterations in cell morphology were evaluated under
bright-field microscopy. (F) A549 cells were infected with different doses of recombinant viruses for 48 hours. Cell survival was
determined by staining with 2% crystal violet. The bar graphs reflect the quantitation of crystal violet staining. (G) A549 cell death was
measured by Annexin V and PI double staining after 12 or 36 hours of infection (10 TCID50/ml, 0.01 MOI). Each bar graph represents
data obtained from three independent experiments. The mean and standard error were analyzed by one-way ANOVA followed by the
Newman-Keuls posttest in GraphPad Prism 5. ns, not significant; ��p<0.01; and ���p<0.001.
https://doi.org/10.1371/journal.pone.0217691.g002
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other single-mutant WSN virus (Fig 2E–2G). These findings indicate that a direct or indirect
functional relationship may exist between NPV100I and NAD248N, possibly promoting influenza
viral pathogenicity.
Recombinant NPV100I NAD248N WSN exhibits enhanced pathogenicity in
vivo
We next evaluated the pathogenic effect of the NPV100I NAD248N WSN virus in BALB/c mice.
Mice were intranasally infected with recombinant WSN influenza viruses (100 μl, 2000
TCID50/ml), and their survival rates were observed over a two-week period. For comparison,
groups of mice were also infected with the NPV100I NAWSN or NPWSN NAD248N WSN virus.
Infection with the NPV100I NAD248N WSN virus caused high mortality, with every mouse tested
dying by 9 days postinfection (d.p.i.) (Fig 3A). In contrast, greatly reduced mortality was
found with infection of either NPV100I NAWSN or parental WSN, with over 40% of NPWSN
NAD248N WSN-infected mice being dead at 15 d.p.i. (Fig 3A). Mice infected with either
NPV100I NAWSN or the parental WSN experienced weight loss but recovered, though infection
with NPWSN NAD248N WSN resulted in nearly 30% weight loss at 15 d.p.i. (Fig 3B).
To better understand the pathogenicity of NPV100I NAD248N WSN, we next investigated the
kinetics of viral replication and IFNβ production at an early time in the lungs of infected mice
to evaluate viral replication alone and ignore factors influencing mouse survival. Viral titers
obtained from the lungs of mice infected with NPV100I NAD248N recombinant WSN were sig-
nificantly higher than those of mice infected with the parental WSN virus (Fig 3C). Further-
more, mice infected with the recombinant NPV100I NAD248N WSN virus were unable to clear
the virus and produced higher levels of IFNβ than did mice infected with the parental WSN
virus (Fig 3D). Altogether, these data strongly indicate that in contrast to control or single-
mutant viruses, the NPV100I NAD248N WSN virus exhibits strong pathogenicity in vivo.
The NPV100I and NAD248N combination enhances the binding of viral RNA
by NP
In contrast to parental or single NPV100I or NAD248N mutant WSN viruses, the replication rate
of NPV100I NAD248N WSN was strongly increased (Fig 2A). To exclude possible variations at
the entry steps of infection, we measured accumulation of the intracellular viral genome at 24
hours relative to the intracellular viral genome at 6 hours postinfection (Fig 4A). In this case,
NPV100I NAD248N WSN again exhibited the highest viral genome accumulation, confirming
that this double mutant virus shows enhanced viral production compared to that of the paren-
tal or single-mutant virus. These results suggest that NPV100I and NAD248N might function
together to increase the overall fitness of infectious influenza viruses.
To address the molecular mechanism of functional synergy between the NPV100I and
NAD248N proteins, we first assessed whether physical interactions between the NP and NA pro-
teins are affected by these substitutions. To this end, mammalian expression plasmids carrying
NPWSN, NPV100I, NAWSN, or NAD248N were generated separately, and their interactions were
assessed in 293T cells. However, no physical interactions between these proteins were observed
(S3 Fig). Therefore, we next hypothesized that the function of one protein might be indirectly
aided by the other protein in the presence of the designated substitution. NP binds to viral
RNA and is a component of the viral ribonucleoprotein (vRNP) complex [16, 17], and V100I
is located near the RNA-binding domain [18] (S4 Fig). We first examined whether the RNA-
binding potential of NP is altered by this substitution using an RNA pulldown assay with bio-
tin conjugated to WSN NS vRNA. Cell lysates from 293T cells transfected with NPWSN or
NPV100I expression plasmids were incubated with labeled WSN NS vRNA, and the RNA-
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bound form of the NP protein was visualized by an immunoblot assay. In contrast to weak
NPWSN binding, enhanced vRNA binding to NPV100I was detected (Fig 4B and 4C). Interest-
ingly, vRNA binding by the NP protein, either NPWSN or NPV100I, was further increased when
NAD248N was coexpressed (Fig 4D and 4E), indicating that NAD248N is able to aid NP protein-
vRNA interactions. Next, an RNA-IP assay was performed in which total lysates of A549 cells
infected with various forms of recombinant WSN viruses were incubated with an anti-NP anti-
body followed by analysis of the bound form of viral RNAs. Although NPV100 protein binding
to viral RNA appeared to increase, the results were not significant. However, NPV100I binding
to viral RNA significantly increased when was NAD248N also present (Fig 4F). These data,
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Fig 4. NP-mediated RNA binding is significantly increased with covarying NPV100I and NAD248N. (A) A549 cells were infected with the indicated recombinant WSN
virus (10 TCID50/ml, 0.01 MOI), and intracellular viral RNA levels were measured at 6 or 24 hours postinfection (h.p.i.). Accumulation of the viral genome was
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along with those of the transfection experiments, confirm that the NPV100I interaction with
viral RNA is strengthened in the presence of NAD248N.
To better understand the altered function of NP proteins by substitution or coexpression
with NAD248N, we examined viral genome replication because NP has been reported to func-
tion in viral genome replication steps along with other PB1/PB2/PA RNA polymerase complex
components [16]. 293T cells were cotransfected with NPWSN, NPV100I, NAWSN, or NAD248N
along with an eGFP reporter plasmid carrying NS vRNA, and the viral RNA-dependent RNA
polymerase (RdRP) activity of NP was assessed by measuring the mean fluorescent intensity of
GFP (Fig 4G). Under all conditions tested, the RdRP activity of the NP protein was not signifi-
cantly altered by single-amino acid substitutions at the 100th position or in combination with
NAD248N expression.
The NAD248N protein is recruited to the lipid raft compartment
Herein, we provide evidence that vRNA-NP assembly as well as viral production are synergisti-
cally enhanced when both NPV100I and NAD248N are present, indicating that the gain of func-
tion effect by NAD248N substitution influences the function of NPV100I, ultimately promoting
viral production. During assembly of newly synthesized influenza viral proteins and vRNPs,
the HA and NA proteins are independently targeted toward lipid rafts [19, 20], which is also
required for the apical targeting of vRNPs [21]. In transfected 293T cells, a large amount of
NAD248N protein was observed in cellular compartments containing lipid raft markers (S5
Fig). Therefore, we hypothesized that intracellular trafficking of the vRNP complex to lipid
rafts is affected by NAD248N, which may explain the enhanced viral production of recombinant
NPV100I NAD248N WSN. To test this hypothesis, we measured the lipid raft trafficking of NA in
recombinant virus-infected A549 cells. Similar to plasmid transfection, more NA protein was
observed in the lipid raft compartment of cells infected with NAD248N WSN (Fig 5A). In this
case, the input expression of NA was also increased after NAD248N WSN infection. Further-
more, statistically significant enhancement of NA localization in the lipid raft compartment
was observed in cells infected with NPV100I NAD248N WSN virus (Fig 5B). These data suggested
that NAD248N mutation causes increased NA levels, which could account for the enhanced NA
lipid raft association.
To determine the functional relationship between enriched NA at lipid rafts and the
enhanced RNA-binding of NP, cells were treated with a myriocin, a serine palmitoyltransfer-
ase inhibitor that depletes sphingolipid synthesis and inhibits lipid raft formation, and then
NP protein binding to RNA was measured. Depletion of the lipid raft compartment in myrio-
cin-treated cells was confirmed by observing cholesterol reduction at the plasma membrane
using FITC-conjugated cholera toxin-B, and we found that NA association with lipid rafts was
reduced by myriocin treatment (S6 Fig). Cells were infected with either NPWSN NAWSN WSN
or NPV100I NAD248N WSN virus, and NP-mediated viral RNA binding was compared in the
lipid raft-depleted condition. In myriocin-treated cells, NP binding to viral RNA was
measured by calculating the ratio between the amount of intracellular viral RNA at 24 h.p.i. versus that at 6 h.p.i. Each bar represents three independent experiments. (B
and D) A biotin-labeled NS vRNA pulldown assay was performed using 293T cell lysates transfected with the indicated plasmids (48 hours). Nonlabelled NS vRNA was
used as a competitor. (C and E) Western blotting data represent one result from three or four repeated independent experiments. (F) RNA immunoprecipitation of NP
proteins was performed using A549 cells infected with the indicated WSN influenza A viruses (10 TCID50/ml, 0.01 MOI, 24 hours). Relative amounts of NP-bound
vRNAs were analyzed by qRT-PCR. (G) 293T cells were transfected with expression plasmids carrying PB2, PB1, and PA along with the designated NP and NA. To
measure RdRP activity, equal amounts of the NS-GFP reporter plasmid were cotransfected. The mean fluorescence intensities (MFI) of GFP-expressing cells measured
by FACS are shown. (C and D) The blots shown are cropped from different parts of the same membrane after stripping. The dot graph was obtained from five
independent experiments, and each individual experiment was normalized to the control. The mean and standard error were analyzed by one-way ANOVA followed by
the Newman-Keuls posttest in GraphPad Prism 5. ns, not significant; �p<0.05; and ��p<0.01.
https://doi.org/10.1371/journal.pone.0217691.g004
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significantly reduced with both NPWSN NAWSN WSN and NPV100I NAD248N WSN infection
(Fig 5C). In addition to virus infection, reduced NP binding to vRNA was observed in myrio-
cin-treated, expression-plasmid-transfected cells (Fig 5D). Taken together, these data indicate
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that enhanced accumulation of NA at lipid rafts might contribute to the enhanced RNA bind-
ing of NP, which does explain the synergistic effect of NPV100I and NAD248N in promoting
influenza virus pathogenicity.
Discussion
In this report, we demonstrate that functional synergy between the covarying NPV100I and
NAD248N mutation pairs of the 2009 pH1N1 IAV explains the enhanced pathogenicity of this
influenza virus. A single-amino acid substitution at the 100th residue of the NP protein
increased its vRNA binding potential, which was significantly enhanced when the NAD248N
protein was present. The ability of the NA protein to be recruited to the lipid raft compart-
ment, which directly influences viral particle release, was also augmented with a single-amino
acid change at the 248th residue of the NA protein. Therefore, our data indicate that the
covarying NPV100I and NAD248N pair functions to boost viral component assembly and virus
particle release, which may explain the increased production of influenza virus (Fig 6).
We utilized amino acid sequence information from 2009 pH1N1 IAV isolates to search for
covarying protein pairs based on the assumption that proteins that function together have a
high probability of coevolution. Although we interpreted high covariation as a sign of a func-
tional relationship, covariation can be affected by many factors in addition to the pressure to
coevolve, and geographic distance, evolutionary distance between viruses, or gene lengths can
influence our results. We consider two possible scenarios if geographic distance dominates
impacts on covariation: 1) covariation among all genes should be very low, as approximately
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Fig 6. Working model of the functional synergy between the covarying NPV100I and NAD248N pair in 2009 pH1N1
IAVs. (A) Normal conditions for WSN influenza A virus production. (B) For recombinant WSN, NPV100I showed
increased vRNA binding, which enhanced viral RNP assembly. Simultaneously, NAD248N exhibited increased
recruitment to the lipid raft compartment, which promoted virus particle release. Although covarying NPV100I and
NAD248N proteins do not physically interact, functional synergy leads to augmented production of the 2009 H1N1
influenza virus.
https://doi.org/10.1371/journal.pone.0217691.g006
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70% (291/417) of examined viral sequences were obtained from a single country (USA); or 2)
the total covariation score should be high because correlation according to distance is very sig-
nificant, even among viruses from the USA. In general, our covariation analysis revealed rela-
tively low correlation coefficients (between -0.104 and 0.253), except for the NP-NA pair
(0.623). The length of a sequence is another potential factor that can affect the probability of
random variation. To address this issue, the similarity value was normalized to the total num-
ber of sequences. Analysis of the covariation results indicated no correlation with sequence
length: the longest genes (PB2, PB1) did not show the highest correlation, and the shortest
genes (NS1, NS2, M2) did not show in relatively small correlations among themselves or with
other genes (S1 Table). Based on this interpretation, we postulated that the influence of
sequence length on covariation was minimal, if at all.
Physically interacting proteins coevolve to complement structural changes at the interaction
surface. When coevolutionary selection pressure is applied to pairs of interacting proteins,
amino acid substitutions in one protein often affect the rates of substitutions in interacting
partners. By measuring correlating variability of amino acid sites among proteins, structural as
well as phylogenetic coevolution can be assessed [12, 14]. Although most molecular coevolu-
tion studies have focused on interacting proteins, accumulating evidence indicates that nonin-
teracting protein pairs with similar functions also coevolve. In fact, on a proteome-wide scale,
analyses of evolutionary rate covariation (ERC) along with physically and genetically interact-
ing proteins and noninteracting but functionally related proteins have revealed significant
ERC [13]. Although biases and limitations are present, diverse analytical tools for measuring
amino acid covariation have been developed and applied, leading to breakthrough studies for
predicting protein structure and interactomes [12, 22]
In general, measuring covariation is extremely useful when employing a molecular
approach to understand virus pathogenicity. For example, covariation between mutations in
the variable site of the V3 loop of the human immunodeficiency virus type 1 envelope protein
has been assessed to identify significant covarying mutations with structural or functional rela-
tionships [23]. In addition, covariation of eight amino acids in the capsid protein of Hibiscus
chlorotic ringspot virus (HCRSV) has been identified as the genetic change responsible for the
loss of virulence after serial passaging [24]. The amino acid covariance of the hepatitis C virus
(HCV) viral coding region in infected patients has been measured before treatment to link
covarying positions with differential responses to therapy [25], and genome-wide analysis of
HCV covariance networks has been applied to identify amino acid pairs predicted to contrib-
ute to therapy failure as well as hub positions with antiviral target potential. In contrast to spe-
cific amino acid site-wise level comparison analysis, we measured the similarity between entire
sequences, which distinguishes our approach from other more typical methods. In this study,
we examined the amino acid covariance of viral proteins of the 2009 pH1N1 influenza virus to
identify genetic factors contributing to the pathogenicity of the 2009 pandemic. A total of 417
whole-genome sequences from independent influenza virus isolates were compared to assess
covariance, and covarying pairs of the influenza viral proteins NA and NP were identified.
However, our analysis has some potential shortcomings. Among the 417 examined isolates,
approximately 70% of the information was obtained from a single country (USA, low geo-
graphic distance), which suggests that our data analysis of predominant amino acid sequences
at variable residues in NP or NA might be affected by limited sequence information.
We demonstrate that WSN with the NPV100I NAD248N pair was highly pathogenic. How-
ever, a low percentage of viruses with the NPV100I NAD248N pair were found among 2009
pH1N1 IAVs, with a naturally occurring frequency of only 4% (Fig 2A). Such an apparent con-
tradiction can also be explained by considering the relatively mild pathogenicity of 2009 pan-
demic influenza. We postulate that highly pathogenic 2009 pH1N1 IAVs may have failed to
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adapt among the host population but that rather mildly pathogenic 2009 pH1N1 IAVs were
well adapted and dominant. It is likely that the most pathogenic virus eliminated its host too
rapidly to propagate, resulting in a small population of infected hosts. Alternatively, the patho-
genic NPV100I and NAD248N combination may have caused a phenotype that prevented spread,
yet we cannot present a possible mechanism that supports this hypothesis.
Influenza NP is a single-stranded RNA (ssRNA)-binding protein that encapsidates the viral
RNA genome to form a ribonucleoprotein particle. NP also interacts with several viral and
host proteins to elicit multiple functions during the virus replication cycle of influenza infec-
tion [18]. NP participates in viral RNA transcription processes through interactions with the
RdRP complex and viral packaging; it also interacts with host factors, such as the human chap-
erone heat shock protein 40, to modulate PKR activation or inhibit IRF3 activation [26]. Both
the sequence comparison and reverse genetics approaches applied to identify substitutions
responsible for the pathogenicity observed in the 2009 pH1N1 influenza outbreak have mainly
been concentrated on the membrane proteins HA and NA, with a limited number of studies
reporting the role of NP. In this study, we observed that the single-amino acid substitution of
V to I at the 100th position near the RNA-binding domain enhanced NP-mediated RNA-bind-
ing ability but not RdRP activity. Interestingly, the increased RNA binding, or rather RNP for-
mation, resulted in enhanced virus production, especially when a covarying amino acid
substitution was present in the NA protein, affecting lipid raft recruitment.
During the final stage of virus assembly, the packaged RNA-protein complex associated
with the intracellular membrane translocates to the apical side of the lipid raft-rich plasma
membrane, and this is a critical step for virus release [27]. We observed that a transfected NA
(D248N) protein or recombinant virus with an NA (D248N) substitution was recruited to the
lipid raft compartment more frequently than was the control protein or virus, respectively.
The D248 residue is located in the extracellular domain of the NA protein, and no reports thus
far suggest a role for lipid raft trafficking within this region [19, 20]. Therefore, we hypothesize
that physical interactions between NA and host factors within the lumen of vesicular endoso-
mal organelles, such as the trans-Golgi apparatus, might be disrupted by this amino acid sub-
stitution. Interestingly, galectin-1, which functions to sort apical glycoproteins or their apical
trafficking, reportedly interacts with influenza virus envelope proteins and controls viral infec-
tivity [28, 29]. Thus, investigating whether the identified substitutions in the NA protein alter
its interaction with host trafficking proteins is warranted.
Covariation analysis of 2009 pH1N1 influenza sequence information revealed covarying
viral proteins and specific amino acid substitutions that synergistically influence the pathoge-
nicity of infection. Although no obvious physical interactions were observed, we experimen-
tally demonstrated that these covarying pairs of genetic factors function together to enhance
viral production. Based on these results, we propose that covariation analysis is needed to
screen genetic factors that do not interact but instead function together.
Materials and methods
Identification of covarying gene pairs
Similarity scores of amino acid sequences were calculated for every pair of isolates for each
influenza viral protein, and covariations of viral proteins were analyzed by Pearson’s correla-
tion coefficient (ρ). The amino acid sequences of influenza virus strains were aligned and com-
pared using parsing methods in Biopython. The similarity score for a viral protein was
calculated as a ratio of matched sequences between two strains among total amino acid
sequences. Similarity scores were calculated for all possible combinatory pairs of pandemic
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strains per influenza protein with general programming using MATLAB.
Similarity strain i; strain jð Þ ¼
Number of matched residues between strain i and strain j
Total number of residues
The degrees of correlated mutations between viral proteins were analyzed by Pearson’s cor-
relation coefficients (ρ) of similarity scores of same-strain pairs using the standard function
corr in MATLAB.
rproteinA;proteinB ¼
Covariance ðsimilarity score of protein A; similarity score of protein BÞ
sðsimilarity of protein AÞ � sðsimilarity of protein BÞ
To identify and quantify degree of variability at each amino acid position in a protein, the
RNA sequence was translated into the amino acid sequence and aligned using standard proce-
dures in Biopython; analysis by general programming was performed using MATLAB. In
addition, the number of strains that had different amino acids compared to the most frequent
amino acid at each position was counted.
The sequence information for the 417 2009 pH1N1 IAVs and the sequence information for
the 267 1948 to 2008 seasonal H1N1 IAVs were obtained from the ISED on December 2011.
Cell culture and reagents
Adenocarcinomic human alveolar basal epithelial cells (A549, ATCC) and human embryonic
kidney cells with SV40 T-antigen (293T, ATCC) were maintained in Dulbecco’s Modified
Eagle’s Medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS) (HyClone)
and 1% penicillin/streptomycin (Invitrogen). Myriocin (Sigma) was dissolved in dimethyl sulf-
oxide (DMSO, Sigma), and DMSO was used as a control.
In vitro virus production and virus infection
Recombinant WSN influenza A virus was generated using an in vitro virus production method
[30]. A total of 12 plasmids, pCAGGS WSN PB2, pCAGGS WSN PB1, pCAGGS WSN PA,
pCAGGS WSN NP 0/14, pHH21 polI WSN PB2, pHH21 polI WSN PB1, pHH21 polI WSN
PA, pHH21 polI WSN NP, pHH21 polI WSN HA, pHH21 polI WSN NA, pHH21 polI WSN
NS, and pHH21 polI WSN M (kindly provided by Drs. Kawaoka and Neumann, Madison-
Wisconsin Univ., USA), were cotransfected into 293T cells using the calcium phosphate
method. For NA or NP substitutions, the pHH21 polI WSN NP or pHH21 polI WSN NA
expression plasmids with designated changes were generated. Twelve hours after transfection,
cells were washed with PBS and further incubated in DMEM containing 10% FBS for 48
hours. The supernatants were harvested, and the recombinant viruses were isolated by sucrose
density gradient (30%/60%) centrifugation. Recombinant viruses were then propagated in
chicken embryonated eggs for 48 hours, and the TCID50/ml values of the recombinant viruses
in A549 cells were calculated.
Recombinant WSN influenza A virus was infected into A549 cells at the indicated titer
(TCID50/ml). Three hours later, the infected cells were washed with PBS to remove semi-infec-
tious nonbound virus and incubated for the indicated time.
Mouse experiments
BALB/cOlaHsd (BALB/c) mice were obtained from Harlan Olac (Bicester, UK). After being
intraperitoneally (i.p.) anesthetized with ketamine (100 mg/kg; Yuhan, Korea) and xylazine
hydrochloride (10 mg/kg; Bayer, Belgium) in PBS, the 6 or 7 mice from each group were
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intranasally (i.n.) injected with WSN influenza A virus (2000 TCID50/ml, 100μl). This experi-
ment was carried out for 15 days, and mice body weight and mortality were checked and mon-
itored every 2 days from the 5th day after the initial virus infection (n = 27). To assess
mortality, mice that lost more than 35% of their initial body weight were immediately eutha-
nized by CO2 inhalation or cervical dislocation (n = 14). At the end of the experiment, the
mice that survived were also euthanized the same way (n = 13). For preparation of the lungs of
infected mice, lungs were extracted after PBS perfusion and kept frozen at -80˚C. The isolated
lungs were homogenized in PBS, and the supernatants were collected by centrifugation at
13,200 rpm for 30 min at 4˚C. To measure titers, A549 cells were treated with homogenate
supernatants from the virus-infected lungs. For mRNA expression, total RNA was prepared
from 200 μl of tissue homogenate.
Ethics statement
The production of recombinant WSN IAVs was performed in compliance with the guidelines
established by the Genetic Recombination Experiment Policy of the Institutional Biosafety
Committee (IBC) at POSTECH under approval number PIBC-008.
Mouse experimental procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) at POSTECH under the standard IACUC guidelines (registration num-
ber: 11-1543061-000268-14) of the Animal and Plant Quarantine Agency (APQA) and Minis-
try of Food and Drug Safety (MFDS) of Korea with permit number POSTECH-2014-0002
(Experimental influenza infection). All mouse experiments were performed in a Biosafety level
2 facility that was accredited by the Korea Centers for Disease Control & Prevention (KCDC).
For the data presented, 27 mice were used, of which 13 were euthanized at end of experiment
and 14 in anticipation of reaching the humane endpoint. Dead mice were not found.
Crystal violet assay & apoptosis analysis
A549 cells in a 24-well plate (2 × 104 cells/well) were infected with recombinant WSN IAV.
After the indicated time, the cells were washed with PBS and fixed with 4% paraformaldehyde
(Sigma) for 10 min at room temperature (RT). After staining with 2% crystal violet (Sigma)
(dissolved in 50% ethanol), the dye crystals were dissolved in a 1% SDS solution at 37˚C for 10
min and analyzed using an EZ Read 400 instrument (Biochrom, UK).
For measuring apoptosis, A549 cells (5 ×105) were infected with the indicated recombinant
WSN IAV for 12 or 36 hours. The cells were stained with Annexin V (BD bioscience) and pro-
pidium iodide (Sigma) in 10 mM HEPES (pH 7.4), 140 mM NaCl, and 2.5 mM CaCl2 for 20
min at RT and analyzed using a FACS caliber flow cytometer (BD Biosciences).
Immunoblot analysis
Cells were lysed in lysis buffer (150 mM NaCl, 25 mM Tris-HCl (pH 7.4), 1% Triton X-100,
0.5% deoxycholic acid, and 0.1% SDS) supplemented with protease inhibitors (1 mM DTT,
2 μg/ml pepstatin, 1.1 mg/ml phenylmethanesulfonyl fluoride, 5 μg/ml aprotinin, 5 μg/ml leu-
peptin, and 1 mM benzamidine). Total cell lysates were separated by SDS-PAGE, and proteins
were transferred to nitrocellulose membranes (Whatman). For immunoblotting, the mem-
branes were blocked in a 6.5% skim milk solution and probed first with primary antibodies
and then with horseradish peroxidase (HRP)-conjugated secondary antibodies. Signals were
visualized using the LAS4000 image reader (Fuji Film) after ECL treatment (Pierce). The fol-
lowing primary antibodies were used: anti-NP (1:2,000, Abcam, ab128193), anti-WSN NA
(1:2,000, Pierce, PA5-32238), anti-Flotillin1 (1:1,000, Santa-Cruz Biotechnology, sc-25506),
anti-M2 (1:1,000, Santa-Cruz Biotechnology, sc-32238), anti-Lamin B2 (1:1,000, Santa-Cruz
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Biotechnology, sc-6216), and anti-GAPDH (1:25,000, Chemcon, MAB374). The secondary
antibodies used for these experiments were as follows: goat anti-mouse HRP-conjugated IgG
(1:50,000, Pierce, 1858413), goat anti-rabbit HRP-conjugated IgG (1:5,000, Pierce, 1858415),
and donkey anti-goat HRP-conjugated IgG (1:5,000, Santa-Cruz Biotechnology, sc-2020). To
measure viral release, equal amounts of cell culture media were loaded into a dot blotter (Bio-
metra, Whatman company) followed by immunoblotting using the anti-M2 antibody.
RdRP activity analysis
293T cells were transfected with the pCAGGS WSN PB2, pCAGGS WSN PB1, pCAGGS WSN
PA, pCAGGS WSN NP 0/14 (WT or V100I), pCAGGS and WSN NA (WT or D248N) expres-
sion vectors along with the pHH21 WSN NS-GFP reporter plasmid. Thirty-six hours after
transfection, GFP-expressing cells were analyzed using a FACS caliber flow cytometer.
Total RNA isolation and real-time quantitative PCR
Total RNA was extracted using RNAiso plus (Takara Bio), and 1 μg was reverse transcribed
with ImProm-II Reverse Transcriptase (Promega) using random primers (Promega). PCR
analysis of the cDNA was performed using a StepOne Plus Real-Time PCR machine (Applied
Biosystems). The 18s rRNA or hGAPDH gene was used as an internal control.
RNA-IP and RNA pulldown assay
RNA-IP was performed as previously described [31]. Briefly, A549 cells (2 × 106) were lysed in
Polysome Lysis Buffer (PLB) (100 mM KCl, 5 mM MgCl2, 10 mM HEPES (pH 7.0), and 0.5%
Nonidet P-40) supplemented with protease inhibitors and 100 U/ml RNAse inhibitor. After
centrifugation at 13,000 rpm, the precleared supernatants were incubated with the anti-NP
antibody and protein A/G beads for 6 hours at 4˚C. After 6 rounds of washing with PLB, the
RNA in the bound fractions was eluted using RNAiso plus.
A modified streptavidin-biotin RNA pulldown assay was performed as previously described
[31]. Linearized pcDNA WSN NS vRNA was transcribed in vitro using T7 polymerase (Pro-
mega) and biotin-UTP (Roche). Biotinylated NS vRNA (2 μg) was purified and incubated with
cell lysates in a buffer (10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 2 mM MgCl2, and 1% Tween-
20) supplemented with protease inhibitor and 100 U/ml RNAse inhibitor. Streptavidin agarose
resin (Pierce) was added at 4˚C for 6 hours. After 6 rounds of washing with incubation buffer,
resin-bound proteins were eluted and analyzed by Western blotting.
Preparation of lipid raft-enriched membrane fractions
Lipid raft-enriched fractions were obtained using a modified TX-100 extraction method [32].
Cells were suspended in prechilled TNE buffer (50 mM Tris-HCl (pH 7.5), 1 mM EDTA, and
150 mM NaCl) with protease inhibitors. After brief sonication, the samples were added to
TNE buffer containing 1% TX-100 at 4˚C for 30 minutes. The samples were then centrifuged
at 13,200 rpm (Eppendorf, 5415R) for 30 minutes to separate the soluble and insoluble
fractions.
Statistics
One-way ANOVA followed by the Newman-Keuls posttest was used to compare differences
between three or more independent experimental groups in all cases. A p value<0.05 was con-
sidered statistically significant, and individual biological experiments consisted of individual
cell culture and virus infection. In general, three or more repeated individual experiments
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were used for each condition, which was sufficient to determine statistically significant
differences.
Supporting information
S1 Fig. Alignment of the WSN NP and NA amino acid sequences compared to those of
PR8.
(PDF)
S2 Fig. Production of recombinant WSN viruses. In vitro virus production-related plasmids
with indicated the NP and NA plasmids were transfected into 293T cells. Virus production
was measured in supernatants by TCA precipitation. The presence of virus or NP-NA proteins
in each sample was determined by Western blotting.
(PDF)
S3 Fig. Location of NP residues 100 / 373 and NA residues 106 / 248 in the 3D structure.
(PDF)
S4 Fig. No physical interaction between NP and NA. The indicated NP and NA protein
expression plasmids were transfected into 293T cells. Physical interaction between proteins
was measured by immunoprecipitation with the anti-NP antibody. Each NP-bound NA pro-
tein was determined by Western blotting.
(PDF)
S5 Fig. Translocalization to the lipid raft compartment was increased by the NA D248N
mutation. The lipid raft-enriched membrane compartment was extracted from 293T cells
transfected with the indicated plasmids. The presence of NA protein in each fraction was
determined by Western blotting.
(PDF)
S6 Fig. NA associated with lipid rafts was reduced by myriocin pretreatment. (A) A549
cells were treated with myriocin (5 μM) or DMSO for 72 hours, and the lipid raft compartment
was visualized by fluorescence microscopy after staining with FITC-conjugated cholera-toxin
B. (B) A549 cells pretreated with myriocin (5 μM, 48 hours) and then infected with NPWSN
NAWSN influenza virus for 24 hours. The level of lipid raft-associated NA protein in the lipid
raft fraction was determined by Western blotting.
(PDF)
S1 Table. Pearson’s correlation coefficient of amino acid pairs of 2009 pH1N1 IAVs.
(PDF)
Acknowledgments
We thank Drs. Kawaoka and Neumann (Madison-Wisconsin Univ., USA) for supplying the
plasmids for in vitro influenza A virus production.
Author Contributions
Data curation: Woo-Jong Kim, Kye-Yeon Hur, Joo-Yeon Yoo.
Formal analysis: Woo-Jong Kim.
Investigation: Woo-Jong Kim, Han Wook Park, Seung-Woo Lee, Joo-Yeon Yoo.
Methodology: Woo-Jong Kim, Kye-Yeon Hur, Joo-Yeon Yoo.
Enhanced influenza pathogenicity by functional synergy between the NPV100I and NAD248N pair
PLOS ONE | https://doi.org/10.1371/journal.pone.0217691 May 31, 2019 17 / 19
Project administration: Joo-Yeon Yoo.
Writing – original draft: Woo-Jong Kim, Kye-Yeon Hur, Han Wook Park, Seung-Woo Lee,
Joo-Yeon Yoo.
Writing – review & editing: Joo-Yeon Yoo.
References
1. Taubenberger JK, Kash JC. Influenza Virus Evolution, Host Adaptation, and Pandemic Formation. Cell
Host & Microbe. 2010; 7(6):440–51. https://doi.org/10.1016/j.chom.2010.05.009 PubMed PMID:
WOS:000279209200005. PMID: 20542248
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a Novel Swine-
Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation
Team. New England Journal of Medicine. 2009; 360(25):2605–15. https://doi.org/10.1056/
NEJMoa0903810 PubMed PMID: WOS:000267060000005. PMID: 19423869
3. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza
virus. Nature. 2009; 459(7249):931–9. https://doi.org/10.1038/nature08157 PubMed PMID:
WOS:000267063500032. PMID: 19525932
4. Cotter CR, Jin H, Chen ZY. A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus
HA Protein Affects Viral Fusion, Stability and Infectivity. Plos Pathogens. 2014; 10(1). https://doi.org/10.
1371/journal.ppat.1003831 PubMed PMID: WOS:000332640900033. PMID: 24391498
5. Takahashi T, Song JS, Suzuki T, Kawaoka Y. Mutations in NA That Induced Low pH-Stability and
Enhanced the Replication of Pandemic (H1N1) 2009 Influenza A Virus at an Early Stage of the Pan-
demic. Plos One. 2013; 8(5). https://doi.org/10.1371/journal.pone.0064439 PubMed PMID:
WOS:000319081900096. PMID: 23696893
6. Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, et al. PB1-F2 Expression by the
2009 Pandemic H1N1 Influenza Virus Has Minimal Impact on Virulence in Animal Models. Journal of
Virology. 2010; 84(9):4442–50. https://doi.org/10.1128/JVI.02717-09 PubMed PMID:
WOS:000276358000030. PMID: 20181699
7. Zhao ZZ, Yi CY, Zhao LZ, Wang SY, Zhou LS, Hu Y, et al. PB2-588I Enhances 2009 H1N1 Pandemic
Influenza Virus Virulence by Increasing Viral Replication and Exacerbating PB2 Inhibition of Beta Inter-
feron Expression. Journal of Virology. 2014; 88(4):2260–7. https://doi.org/10.1128/JVI.03024-13
PubMed PMID: WOS:000331125500035. PMID: 24335306
8. Zhu WF, Zhu Y, Qin K, Yu ZJ, Gao RB, Yu HY, et al. Mutations in Polymerase Genes Enhanced the Vir-
ulence of 2009 Pandemic H1N1 Influenza Virus in Mice. Plos One. 2012; 7(3). https://doi.org/10.1371/
journal.pone.0033383 PubMed PMID: WOS:000303309000023. PMID: 22438920
9. Hale BG, Steel J, Medina RA, Manicassamy B, Ye JQ, Hickman D, et al. Inefficient Control of Host
Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein. Journal of Virology.
2010; 84(14):6909–22. https://doi.org/10.1128/JVI.00081-10 PubMed PMID: WOS:000278935700002.
PMID: 20444891
10. Brooke CB, Ince WL, Wei JJ, Bennink JR, Yewdell JW. Influenza A virus nucleoprotein selectively
decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility.
Proceedings of the National Academy of Sciences of the United States of America. 2014; 111
(47):16854–9. https://doi.org/10.1073/pnas.1415396111 PubMed PMID: WOS:000345662700053.
PMID: 25385602
11. Fraser HB, Hirsh AE, Wall DP, Eisen MB. Coevolution of gene expression among interacting proteins.
Proceedings of the National Academy of Sciences of the United States of America. 2004; 101
(24):9033–8. https://doi.org/10.1073/pnas.0402591101 PubMed PMID: WOS:000222104900038.
PMID: 15175431
12. Codoner FM, Fares MA. Why Should We Care About Molecular Coevolution? Evolutionary Bioinformat-
ics. 2008; 4:29–38. PubMed PMID: WOS:000264677700004.
13. Clark NL, Alani E, Aquadro CF. Evolutionary rate covariation reveals shared functionality and coexpres-
sion of genes. Genome Research. 2012; 22(4):714–20. https://doi.org/10.1101/gr.132647.111 PubMed
PMID: WOS:000302203800012. PMID: 22287101
14. Goh CS, Bogan AA, Joachimiak M, Walther D, Cohen FE. Co-evolution of proteins with their interaction
partners. Journal of Molecular Biology. 2000; 299(2):283–93. https://doi.org/10.1006/jmbi.2000.3732
PubMed PMID: WOS:000087446500001. PMID: 10860738
Enhanced influenza pathogenicity by functional synergy between the NPV100I and NAD248N pair
PLOS ONE | https://doi.org/10.1371/journal.pone.0217691 May 31, 2019 18 / 19
15. Yang S, Lee JY, Lee JS, Mitchell WP, Oh HB, Kang C, et al. Influenza sequence and epitope database.
Nucleic Acids Research. 2009; 37:D423–D30. https://doi.org/10.1093/nar/gkn881 PubMed PMID:
WOS:000261906200077. PMID: 19015128
16. Biswas SK, Boutz PL, Nayak DP. Influenza virus nucleoprotein interacts with influenza virus polymer-
ase proteins. Journal of Virology. 1998; 72(7):5493–501. PubMed PMID: WOS:000074160500021.
PMID: 9621005
17. Kunitoshi Yamanaka AI, and Kyosuke Nagata. Reconstitution of Influenza Virus RNA-Nucleoprotein
Complexes Structurally Resembling Native Viral Ribonucleoprotein Cores. the journal of biological
chemistry. 1990;265.
18. Portela A, Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to
virus replication. Journal of General Virology. 2002; 83:723–34. https://doi.org/10.1099/0022-1317-83-
4-723 PubMed PMID: WOS:000174503100001. PMID: 11907320
19. Zhang J, Pekosz A, Lamb RA. Influenza virus assembly and lipid raft microdomains: a role for the cyto-
plasmic tails of the spike glycoproteins. Journal of Virology. 2000; 74(10):4634–44. https://doi.org/10.
1128/jvi.74.10.4634-4644.2000 PubMed PMID: WOS:000086629400021. PMID: 10775599
20. Ohkura T, Momose F, Ichikawa R, Takeuchi K, Morikawa Y. Influenza A Virus Hemagglutinin and Neur-
aminidase Mutually Accelerate Their Apical Targeting through Clustering of Lipid Rafts. Journal of Virol-
ogy. 2014; 88(17):10039–55. https://doi.org/10.1128/JVI.00586-14 PubMed PMID:
WOS:000341232300046. PMID: 24965459
21. Carrasco M, Amorim MJ, Digard P. Lipid raft-dependent targeting of the influenza A virus nucleoprotein
to the apical plasma membrane. Traffic. 2004; 5(12):979–92. https://doi.org/10.1111/j.1600-0854.2004.
00237.x PubMed PMID: WOS:000224864500007. PMID: 15522099
22. Talavera D, Lovell SC, Whelan S. Covariation Is a Poor Measure of Molecular Coevolution. Molecular
Biology and Evolution. 2015; 32(9):2456–68. https://doi.org/10.1093/molbev/msv109 PubMed PMID:
WOS:000361981900019. PMID: 25944916
23. Bette T. M. Koreber RMF, David H. Wolpert, and Alan S. Lapedes. Covariation of mutations in the V3
loop of human immunodeficiency virus type 1 envelope protein: An information theoretic analysis. Pro-
ceedings of the National Academy of Sciences of the United States of America. 1993;Vol. 90:5. Epub
7180.
24. Liang XZ, Lee BTK, Wong SM. Covariation in the capsid protein of Hibiscus chlorotic ringspot virus
induced by serial passaging in a host that restricts movement leads to avirulence in its systemic host.
Journal of Virology. 2002; 76(23):12320–4. https://doi.org/10.1128/JVI.76.23.12320-12324.2002
PubMed PMID: WOS:000179083700053. PMID: 12414972
25. Aurora R, Donlin MJ, Cannon NA, Tavis JE, Virahep CSG. Genome-wide hepatitis C virus amino acid
covariance networks can predict response to antiviral therapy in humans. Journal of Clinical Investiga-
tion. 2009; 119(1):225–36. https://doi.org/10.1172/JCI37085 PubMed PMID: WOS:000262139900025.
PMID: 19104147
26. Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, et al. Influenza A Virus Nucleoprotein
Exploits Hsp40 to Inhibit PKR Activation. Plos One. 2011; 6(6). https://doi.org/10.1371/journal.pone.
0020215 PubMed PMID: WOS:000291730000009. PMID: 21698289
27. Chazal N, Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiology and Molecular
Biology Reviews. 2003; 67(2):226–+. https://doi.org/10.1128/MMBR.67.2.226-237.2003 PubMed
PMID: WOS:000183450500004. PMID: 12794191
28. Delacour D, Koch A, Jacob R. The Role of Galectins in Protein Trafficking. Traffic. 2009; 10(10):1405–
13. https://doi.org/10.1111/j.1600-0854.2009.00960.x PubMed PMID: WOS:000269732500003. PMID:
19650851
29. Yang ML, Chen YH, Wang SW, Huang YJ, Leu CH, Yeh NC, et al. Galectin-1 Binds to Influenza Virus
and Ameliorates Influenza Virus Pathogenesis. Journal of Virology. 2011; 85(19):10010–20. https://doi.
org/10.1128/JVI.00301-11 PubMed PMID: WOS:000296253900033. PMID: 21795357
30. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, et al. Generation of influenza A viruses
entirely from cloned cDNAs. Proceedings of the National Academy of Sciences of the United States of
America. 1999; 96(16):9345–50. https://doi.org/10.1073/pnas.96.16.9345 PubMed PMID:
WOS:000081835500103. PMID: 10430945
31. Jo JH, Chung TM, Youn H, Yoo JY. Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53
mRNA to control p53-mediated apoptosis. Nature Communications. 2014; 5. https://doi.org/10.1038/
ncomms6433 PubMed PMID: WOS:000345625000013. PMID: 25388829
32. Radeva G, Sharom FJ. Isolation and characterization of lipid rafts with different properties from RBL-
2H3 (rat basophilic leukaemia) cells. Biochemical Journal. 2004; 380:219–30. https://doi.org/10.1042/
BJ20031348 PubMed PMID: WOS:000221735000024. PMID: 14769131
Enhanced influenza pathogenicity by functional synergy between the NPV100I and NAD248N pair
PLOS ONE | https://doi.org/10.1371/journal.pone.0217691 May 31, 2019 19 / 19
